IRIS
Bartoletti, Michele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.487
AS - Asia 3.291
SA - Sud America 711
EU - Europa 635
AF - Africa 66
OC - Oceania 9
Totale 8.199
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.363
SG - Singapore 1.753
CN - Cina 707
BR - Brasile 584
VN - Vietnam 402
IT - Italia 130
HK - Hong Kong 111
IE - Irlanda 101
FI - Finlandia 91
CA - Canada 54
DE - Germania 47
GB - Regno Unito 47
RU - Federazione Russa 44
MX - Messico 42
BD - Bangladesh 41
IN - India 40
AR - Argentina 39
FR - Francia 36
MY - Malesia 32
IQ - Iraq 30
EC - Ecuador 28
NL - Olanda 27
JP - Giappone 26
PL - Polonia 24
ZA - Sudafrica 23
ID - Indonesia 22
ES - Italia 21
TR - Turchia 15
CO - Colombia 14
PE - Perù 12
PK - Pakistan 12
PY - Paraguay 12
UZ - Uzbekistan 12
SA - Arabia Saudita 11
SE - Svezia 10
EG - Egitto 9
PH - Filippine 9
UA - Ucraina 9
AU - Australia 8
LT - Lituania 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
MA - Marocco 7
IR - Iran 6
JM - Giamaica 6
KE - Kenya 6
KR - Corea 6
NP - Nepal 6
RS - Serbia 6
TN - Tunisia 6
AT - Austria 5
BH - Bahrain 5
AL - Albania 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
ET - Etiopia 4
IL - Israele 4
JO - Giordania 4
KZ - Kazakistan 4
LB - Libano 4
SK - Slovacchia (Repubblica Slovacca) 4
TW - Taiwan 4
UY - Uruguay 4
AZ - Azerbaigian 3
BG - Bulgaria 3
GR - Grecia 3
LV - Lettonia 3
PA - Panama 3
PS - Palestinian Territory 3
SV - El Salvador 3
DK - Danimarca 2
GT - Guatemala 2
GY - Guiana 2
HN - Honduras 2
KG - Kirghizistan 2
PT - Portogallo 2
SN - Senegal 2
TH - Thailandia 2
TJ - Tagikistan 2
AM - Armenia 1
BB - Barbados 1
BE - Belgio 1
BO - Bolivia 1
CD - Congo 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ER - Eritrea 1
HR - Croazia 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MT - Malta 1
NI - Nicaragua 1
OM - Oman 1
PR - Porto Rico 1
Totale 8.193
Salva come PNG Salva come JPEG
Città #
Dallas 921
Singapore 690
Ashburn 556
San Jose 455
The Dalles 314
Shanghai 249
Boardman 134
Ho Chi Minh City 131
Los Angeles 122
New York 117
Hong Kong 105
Dublin 101
Beijing 97
Santa Clara 93
Helsinki 91
Hanoi 79
São Paulo 57
Buffalo 36
Milan 33
Rio de Janeiro 23
Da Nang 22
Orem 22
Haiphong 20
Moscow 20
Toronto 20
Warsaw 20
Mexico City 19
Tokyo 18
Seattle 17
Kuala Lumpur 16
Baghdad 15
Brooklyn 15
Chandler 14
Curitiba 14
Dhaka 14
Montreal 14
Brasília 13
Amsterdam 12
Assago 12
Johannesburg 12
Phoenix 12
Chennai 11
Council Bluffs 11
Cuenca 11
Tashkent 11
Belo Horizonte 10
Boston 10
Hangzhou 10
Charlotte 9
Atlanta 8
Bắc Ninh 8
Cairo 8
Chicago 8
Jeddah 8
London 8
Manchester 8
San Francisco 8
Lima 7
Paris 7
Quito 7
Asunción 6
Frankfurt am Main 6
Genoa 6
Guangzhou 6
Hải Dương 6
Nairobi 6
Naples 6
Pasadena 6
Porto Alegre 6
Quảng Ngãi 6
Ribeirão Preto 6
Sorocaba 6
Stockholm 6
Vũng Tàu 6
Wilmington 6
Ankara 5
Biên Hòa 5
Go Vap 5
Guayaquil 5
Ha Long 5
Hillsboro 5
Manaus 5
Mauá 5
Queens 5
Quảng Ninh 5
Ribeirão das Neves 5
São Luís 5
Thái Nguyên 5
Wuhan 5
Addis Ababa 4
Barcelona 4
Belfast 4
Brisbane 4
Campinas 4
Campo Grande 4
Can Tho 4
Casablanca 4
Changsha 4
Chengdu 4
Dubai 4
Totale 5.117
Salva come PNG Salva come JPEG
Nome #
What is the impact of anti-enterococcal empirical therapy on survival of patients with enterococcal bloodstream infections? 433
COVID-19 Vaccination Still Makes Sense: Insights on Pneumonia Risk and Hospitalization from a Large-Scale Study at an Academic Tertiary Center in Italy 378
Beyond the distance between juridic and scientific decision-making process: An evidence-based prediction algorithm for professional liability assessment in healthcare-associated infections 111
Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study 107
Ischemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis 100
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future 91
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: Results from a multicenter case-control-control study 83
Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS‐CoV‐2 infection 82
Incidence and outcome of early Candida peritonitis after liver and pancreas transplantation 82
Blood Hemoglobin Substantially Modulates the Impact of Gender, Morbid Obesity, and Hyperglycemia on COVID-19 Death Risk: A Multicenter Study in Italy and Spain 80
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 79
Management of Metastatic Endometrial Cancer: Physicians’ Choices Beyond the First Line. A MITO Survey 76
The long Pentraxin PTX3 serves as an early predictive biomarker of co-infections in COVID-19 72
Bloodstream infections in patients with liver cirrhosis 71
(18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis 70
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 70
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 67
Meningitis caused by toscana virus is associated with strong antiviral response in the CNS and altered frequency of blood antigen-presenting cells 66
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections 64
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 64
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 64
CEFTO-CURE study: CEFTObiprole Clinical Use in Real-lifE – a multi-centre experience in Italy 63
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients 63
Epidemiology and Resistance Profiles of Bacteria Isolated From Blood Samples in Septic Patients at Emergency Department Admission: A 6-Year Single Centre Retrospective Analysis From Northern Italy 63
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study 62
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 62
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia 61
Management of metastatic endometrial cancer: physicians’ choices beyond the first line after approval of checkpoint inhibitors 60
Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-alpha in HIV-infected patients treated with ritonavir-boosted protease inhibitors 59
Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae 59
Treatment duration for Escherichia coli bloodstream infection and outcomes: Retrospective single-centre study 59
Olaparib beyond progression compared with platinum chemotherapy after secondary cytoreductive surgery in patients with recurrent ovarian cancer: phase III randomized, open-label MITO 35b study, a project of the MITO-MANGO groups 59
Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure 58
Advances in the therapy of bacterial bloodstream infections 58
Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations 58
A descriptive case series of PK/PD target attainment and microbiological outcome in critically ill patients with documented severe XDR Acinetobacter baumannii BSI and/or VAP treated with cefiderocol 57
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy 57
Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis 56
Prevention of infections in nursing homes: Antibiotic prophylaxis versus infection control and antimicrobial stewardship measures 56
Distinct chromosomal mutation associated with cefiderocol resistance in Acinetobacter baumannii: a combined bioinformatics and mass spectrometry approach to unveil and validate the in vivo-acquired chemoresistance 56
2018 WSES/SIS-E consensus conference: Recommendations for the management of skin and soft-tissue infections 56
MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy 55
An Antimicrobial Stewardship Program Based on Systematic Infectious Disease Consultation in a Rehabilitation Facility 55
Laboratory and clinical management capacity for invasive fungal infections: the Italian landscape 55
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 55
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 54
Carbapenemase-producing Enterobacteriaceae in transplant patients 54
Opportunistic infections in end stage liver disease 53
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 53
Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience 53
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections 53
A retrospective multicentre study on dalbavancin effectiveness and cost-evaluation in sternotomic wound infection treatment: DALBA SWIT Study 53
Use of critical care resources during the first 2 weeks (February 24–March 8, 2020) of the Covid-19 outbreak in Italy 53
Severe infections in patients with chronic lymphocytic leukemia included in trials investigating BTK and BCL2 inhibitors 52
Dialysis-associated infection prevention and surveillance trial: an easy, feasible and effective bundle for infection prevention 52
Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22) 52
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 51
Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018 51
Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: A case series 51
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 51
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment 50
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study 50
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial 50
Toscana virus infections in northern Italy: laboratory and clinical evaluation 49
Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort 49
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 49
How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre 49
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 49
Epidemiology and outcome of candidemia in internal medicine wards: A regional study in Italy 48
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis 48
ESCMID COVID-19 living guidelines: drug treatment and clinical management 48
Klebsiella pneumoniae bloodstream infection epidemiology and impact of inappropriate empirical therapy 48
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 48
Increase in invasive group A streptococcal infections in Milan, Italy: a genomic and clinical characterization 48
Risk factors for candidemia in hospitalized patients with liver cirrhosis: a multicenter case-control-control study 47
Microbiology of periprosthetic infections following implant-based breast reconstruction surgery: a multicentric retrospective study 47
Non-fermentative gram-negative bloodstream infection in northern Italy: a multicenter cohort study 47
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 47
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 47
Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study 46
COVID-19-associated pulmonary aspergillosis, March-August 2020 45
Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation 45
Serum bactericidal titres for monitoring antimicrobial therapy: current status and potential role in the management of multidrug-resistant Gram-negative infections 45
Management of bacterial and fungal infections in cirrhosis: The MDRO challenge 45
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 45
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group 44
Outcome of early treatment of SARS‐CoV‐2 infection in patients with haematological disorders 44
The Gut Microbiota of Critically Ill Patients With COVID-19 44
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study 44
Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in Candida spp colonized patients 44
Clinical experience with dalbavancin for the treatment of deep sternal wound infection 44
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study 43
The role of extended infusion β-lactams in the treatment of bloodstream infections in patients with liver cirrhosis 43
Risk Factors for Infection With Carbapenem-Resistant Klebsiella pneumoniae After Liver Transplantation: The Importance of Pre- and Posttransplant Colonization 43
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 43
Multidrug-Resistant Bacterial Infections in Solid Organ Transplant Candidates and Recipients 42
Use of meropenem in treating carbapenem-resistant Enterobacteriaceae infections 42
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use 42
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective study 42
Quality of care indicators in the MAnageMent of BlOOdstream infections caused by Enterobacteriaceae (MAMBOO-E study): state of the art and research agenda 42
Totale 6.333
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.027
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.027
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/20224 0 0 0 1 0 0 0 1 0 0 2 0
2022/2023148 6 0 3 5 1 5 0 5 6 3 111 3
2023/20241.048 65 70 204 37 62 171 89 52 17 51 118 112
2024/20251.580 31 8 19 39 35 203 89 97 285 467 141 166
2025/20265.589 556 617 832 397 227 252 1.213 242 246 385 329 293
Totale 8.380